Related by context. All words. (Click for frequent words.) 77 postmenopausal breast cancer 71 pre menopausal 69 endometrial cancer 68 spontaneous preterm delivery 66 premenopausal 66 oophorectomy 65 hormone therapy estrogen 65 bowel polyps 65 endometrial cancers 65 folate intake 65 colorectal adenomas 65 lobular cancer 65 testosterone supplementation 64 colorectal adenoma 64 atypical hyperplasia 64 elevated CRP 64 advanced adenomas 64 colorectal neoplasia 64 polycystic ovary syndrome PCOS 64 BRCA gene mutations 64 endometrial hyperplasia 64 anovulatory infertility 64 ovulatory cycles 63 venous thrombosis 63 endometriosis ovarian cysts 63 premenopausal women 63 post menopausal 63 endogenous estrogen 63 BRCA1 mutations 63 preterm delivery 63 nonpregnant women 62 tibolone 62 colorectal polyps 62 magnesium intake 62 invasive breast cancer 62 BRCA2 mutations 62 coronary calcification 62 postmenopausal hormones 62 SHBG levels 62 dietary calcium intake 62 chlamydial infection 62 ovarian hormones 62 beta carotene supplements 62 colon tumors 62 distal colon cancer 62 beta carotene supplementation 62 ovulatory infertility 62 irregular menstrual cycles 62 folate supplementation 62 hydroxyvitamin D levels 62 ductal breast cancer 61 recurrent miscarriage 61 ductal cancer 61 nonmelanoma skin cancer 61 recurrent miscarriages 61 vasomotor symptoms 61 benign breast 61 cervical lesions 61 denser breasts 61 recurrent UTI 61 gestational diabetes mellitus 61 bilateral oophorectomy 61 parous women 61 osteoporotic fracture 61 advanced adenoma 61 haemorrhagic stroke 61 breast endometrial 61 plasma homocysteine levels 61 mammary tumors 61 estrogen progestin therapy 61 colon polyps 61 spontaneous preterm birth 61 BRCA mutation 61 serum vitamin D 61 bacterial vaginosis 61 transferrin saturation 61 thyroid hormone levels 61 adenoma 61 vertebral fracture 61 colorectal cancer incidence 61 nonmelanoma skin cancers 61 polycystic ovary syndrome 61 lobular breast cancer 61 neurodevelopmental outcomes 60 estrogen receptor negative 60 postoperative mortality 60 polyp recurrence 60 CVD mortality 60 selenium supplementation 60 premenstrual syndrome PMS 60 postmenopausal women 60 postmenopausal hormone replacement 60 breast tenderness 60 postmenopausal 60 Leitzmann 60 alpha carotene 60 pCR 60 uterine cancers 60 basal cell nevus syndrome 60 dietary calcium 60 shorter telomeres 60 GnRH agonists 60 subclinical hypothyroidism 60 folic acid intake 60 recurrent VTE 60 slow metabolizers 60 BRCA mutations 60 endometrial carcinoma 60 intravenous bisphosphonates 59 postmenopausal hormone 59 oropharyngeal cancer 59 lignan intake 59 chorioamnionitis 59 knee osteoarthritis 59 perimenopausal women 59 Chlamydia infection 59 Calcium intake 59 recurrent wheezing 59 subclinical hyperthyroidism 59 oestradiol 59 basal cell carcinomas 59 adenomas 59 antioxidant nutrients 59 colorectal polyp 59 pre cancerous lesions 59 folate deficiency 59 preterm deliveries 59 carotid stenosis 59 periodontal gum disease 59 brain shrinkage 59 mammographic density 59 benign growths 59 selenium intake 59 spine fractures 59 cardiovascular mortality 59 gallstone disease 59 calcium supplementation 59 calcium intakes 59 T1DM 59 knee OA 59 primary ovarian insufficiency 59 colorectal tumors 59 serum selenium 59 CLA supplementation 59 precancerous colon polyps 59 neurodevelopmental outcome 59 polycystic ovarian syndrome PCOS 59 osteoporotic fractures 59 BRCA mutation carriers 59 menarche 59 SRBD 58 chemopreventive agent 58 serum lipid levels 58 axillary lymph nodes 58 calcium intake 58 hereditary breast cancer 58 gamma tocopherol 58 dose oral contraceptives 58 salpingo oophorectomy 58 elevated triglyceride levels 58 BRCA gene mutation 58 dietary antioxidants 58 menthol smokers 58 Oral contraceptives 58 atypia 58 CMV infection 58 homocysteine concentrations 58 estrogen metabolites 58 bowel cancers 58 amenorrhea 58 habitual snoring 58 testicular tumors 58 dysfunctional voiding 58 precancerous cervical 58 elevated LDL cholesterol 58 menopausal hormone therapy 58 contralateral breast cancer 58 abnormal mammograms 58 singleton pregnancies 58 overt hepatic encephalopathy HE 58 androgen deprivation 58 dose ionizing radiation 58 nonvertebral fracture 58 gestational hypertension 58 antioxidant intake 58 urinary tract symptoms LUTS 58 postmenopausal hormone therapy 58 MetS 58 venous blood clots 58 antioxidant supplementation 58 breast tissue 58 nonfasting triglyceride levels 58 nonvertebral fractures 58 hip BMD 58 estrogen deficiency 58 NNRTI resistance 58 subfertility 58 subclinical atherosclerosis 58 gestational diabetes mellitus GDM 58 dietary folate intake 58 adenoma recurrence 58 precancerous lesions 58 breastfed infants 58 oral contraceptive pills 58 estrogen therapy 58 breast cancer recurrence 58 obese postmenopausal 58 adrenal function 58 chronic prostatitis 58 artery calcification 58 serum uric acid 58 Vitamin D supplements 58 atopic disease 57 serum calcium levels 57 carotid IMT 57 BRCA2 mutation carriers 57 hormone receptor negative 57 cranial irradiation 57 estrogen 57 choline intake 57 MGUS 57 mild gestational diabetes 57 thigh circumference 57 pelvic girdle pain 57 Estrogen therapy 57 obese adolescents 57 hemorrhagic complications 57 vitamin D inadequacy 57 untreated celiac disease 57 irregular menstrual periods 57 placental malaria 57 HNSCC 57 locoregional recurrence 57 lobular carcinoma 57 dietary fiber intake 57 cardiovascular disease CVD 57 MMSE scores 57 nulliparous women 57 venous thromboembolism 57 probiotic supplementation 57 mineral density 57 nonfasting triglycerides 57 poorer prognosis 57 unmeasured factors 57 DHEAS 57 invasive ductal 57 anastrozole 57 DMPA 57 Folic acid supplements 57 recurrent UTIs 57 undergone hysterectomy 57 Prostatitis 57 obstetric complications 57 antenatal depression 57 thiazide diuretics 57 invasive ductal breast cancer 57 antigen PSA 57 progestins 57 urate levels 57 telomere lengths 57 anal cancers 57 lobular involution 57 uterine tumors 57 phytoestrogen intake 57 cardiorespiratory fitness 57 polycystic ovarian syndrome 57 recurrent venous thromboembolism 57 glandular tissue 57 abdominally obese 57 vitamin D insufficiency 57 BRCA1 mutation carriers 57 Ovary removal 57 body fatness 57 Soy isoflavones 57 squamous cell cancers 57 HPV infection 57 pre cancerous polyps 57 testicular germ cell 57 premature menopause 57 colorectal neoplasms 57 thromboembolic disease 57 statin medications 57 narcolepsy cataplexy 56 LDL cholesterol levels 56 N telopeptide 56 lumbar spine bone 56 perioperative morbidity 56 dysglycemia 56 GSTT1 56 prostate carcinogenesis 56 HER2 positive cancers 56 undergoing radical prostatectomy 56 varicocele 56 thrombotic events 56 elevated homocysteine 56 atypical fractures 56 vitamin B# supplements 56 acrylamide intake 56 flutamide 56 axillary node 56 renal cell carcinomas 56 Hilakivi Clarke 56 APOE e4 56 abnormal Pap test 56 vitamin D supplementation 56 cerebral infarction 56 femoral neck BMD 56 BRCA2 mutation 56 strontium ranelate 56 heart disease 56 disease NAFLD 56 mutated BRCA1 56 BRCA carriers 56 EBV infection 56 HPV infections 56 carotid plaque 56 definite stent thrombosis 56 serum testosterone levels 56 neural tube birth defects 56 hereditary predisposition 56 elevated depressive symptoms 56 Wactawski Wende 56 2D 4D ratio 56 conjugated estrogen 56 dentinal hypersensitivity 56 naturally occurring estrogen 56 BRCA2 carriers 56 hippocampal volume 56 NP CRNs 56 faulty BRCA genes 56 abnormal lipid 56 thyrotropin levels 56 atopy 56 severe periodontitis 56 folic acid supplementation 56 atypical ductal hyperplasia 56 gynecologic malignancy 56 keloids 56 genital HPV infections 56 colorectal cancer 56 PHPT 56 oral contraception 56 elevated LDL 56 mild analgesics 56 abnormal vaginal bleeding 56 vitamin D intake 56 GSTM1 56 venous thromboembolic events 56 estrogen hormone therapy 56 vertebral fractures 56 plasma folate 56 lipid lowering therapy 56 fructose intake 56 chlamydia infections 56 CHD mortality 56 phytoestrogen 56 prostate cancer CaP 56 iodine intake 56 NAFLD 56 uncomplicated pregnancies 56 antioxidant supplements 56 bone mineral 56 hormone estradiol 56 intestinal polyps 56 Calcium supplements 56 atypical femur fractures 56 biologic plausibility 56 ovarian tumors 56 bilirubin levels 56 cryptorchidism 56 genital ulcers 56 atrophic gastritis 56 testosterone secretion 56 Breastfed babies 56 synthetic estrogens 56 hormones estrogen 56 systemic lupus erythematosus SLE 56 DHA supplementation 56 highest quintile 56 conjugated equine estrogen 56 esophageal adenocarcinoma 56 Cochrane reviewers 56 coronary artery calcification 56 fasting glucose levels 56 Alvergne 56 androgenic hormones 56 incidentalomas 56 amino acid homocysteine 56 Triglyceride levels 56 circulating estrogens 56 serum PSA 56 Folate deficiency 56 depressive symptoms 56 selenium supplements 56 Moderate drinkers 56 Michael Leitzmann 56 hyperemesis 56 born preterm 56 digestive tract cancers 56 androgen deficiency 56 modifiable risk 56 liver transplant recipients 56 multivitamin supplements 56 SLNB 56 PBDE chemicals 56 symptomatic fibroids 56 fragility fractures 56 oncogenic HPV 56 cardiovascular disease 56 HER2 expression 56 arterial calcification 56 postoperative AF 56 Adjuvant chemotherapy 56 Uterine cancer 55 AVODART 55 breastfed exclusively 55 shorter telomere length 55 APOE ε4 55 mycophenolate mofetil 55 oesophageal adenocarcinoma 55 estrogen pills 55 Heavy menstrual bleeding 55 cardio vascular disease 55 invasive carcinoma 55 adiponectin levels 55 endometrial thickness 55 plasma selenium 55 TGFBR1 * 6A 55 hormone therapy HT 55 elevated triglycerides 55 CIN3 55 frequently benign tumor 55 orofacial clefts 55 genital ulcer disease 55 oral contraceptive pill 55 abnormal mammogram 55 prostate pancreatic 55 sex hormone estrogen 55 leiomyomas 55 IV bisphosphonates 55 osteopenic 55 BRCA1 mutation 55 synthetic progestin 55 atherogenic dyslipidemia 55 alpha tocopherol 55 serum testosterone 55 neural tube defect 55 urinary oxalate 55 Statin therapy 55 drank colas 55 hypertrophic scars 55 colon adenomas 55 oropharyngeal cancers 55 glycemic diet 55 serum PTH 55 ocular toxicity 55 polycystic ovaries 55 cardio protective 55 precancerous tumors 55 dietary glycemic index 55 bacterial vaginosis BV 55 genistein 55 cerebral microbleeds 55 saturated fat intake 55 Colorectal cancer incidence 55 perioperative mortality 55 VUR 55 thyroid nodules 55 genital HPV infection 55 receptive anal intercourse 55 cervical vaginal 55 soy isoflavones 55 thrombotic complications 55 FUS protein 55 ovarian function 55 estrone 55 improves insulin sensitivity 55 fibroids endometriosis 55 adjuvant radiation 55 arterial stiffening 55 coronary heart 55 fetal malformations 55 CaP 55 postnatally 55 RBP4 levels 55 trivial Klatsky 55 ticlopidine 55 serum phosphate 55 noncancer 55 postoperative pulmonary 55 troponin T 55 follicular adenoma 55 postoperative complications 55 postoperative delirium 55 adenomatous polyps 55 preeclampsia 55 contralateral breast 55 hydroxychloroquine 55 estradiol 55 ximelagatran 55 cardio metabolic 55 Dr Zorbas 55 singleton pregnancy 55 prophylactic oophorectomy 55 GBA mutations 55 palmitoleate 55 postoperative morbidity 55 persistent pulmonary hypertension 55 lipid abnormalities 55 phytoestrogens 55 carotid plaques 55 chronic periodontitis 55 Premenopausal women 55 untreated hypothyroidism 55 irregular menses 55 UVB exposure 55 thromboembolism 55 serum homocysteine 55 GSTM1 gene 55 cardiovascular morbidity 55 ovarian cancer 55 upper gastrointestinal bleeding 55 non fasting triglycerides 55 placenta praevia 55 HGPIN 55 tamoxifen Nolvadex ® 55 pre eclamptic 55 FeNO 55 waist circumferences 55 breast cancers 55 prostate cancer PCa 55 HDL2 55 SERMs 55 vitamin B# deficiency 55 blistering sunburns 55 glycated hemoglobin levels 55 transfusion syndrome 55 flavonoid intake 55 oral bisphosphonates 55 cosmetic breast implants 55 cancerdefine 55 enterovirus infection 55 serum calcium 55 genital herpes infections 55 recurrent preterm birth 55 urinary symptoms 55 metabolic syndrome MetS 55 Schaffir 55 ApoE4 55 unexplained stillbirth 55 hip fracture 55 Rectal cancer 55 basal cell carcinoma BCC 55 glucose intolerance 55 nondepressed 55 hip fractures 55 epithelial ovarian cancer 55 urinary tract symptoms 55 prenatal exposures 55 serum estradiol 55 calorie diets 55 acute GVHD 55 carotid atherosclerosis 55 thromboembolic events 55 benign proliferative breast 55 breast carcinoma 55 endometrial lining 55 bisphosphonate drugs 55 undergoing hysterectomy 55 HbA1C levels 55 HPV# 55 osteoporotic 55 inherited predisposition 55 congenital abnormalities 55 IUGR 55 homocysteine levels 55 clinically insignificant 54 organophosphate exposure 54 axillary node dissection 54 testicular cancers 54 migraineurs 54 progestogen 54 URTI 54 prescribed statins 54 pre cancerous growths 54 microbleeds 54 amenorrhoea 54 NPH insulin 54 confidence interval #.#-#.# 54 fat diets 54 neurodevelopmental impairment 54 HER2 positive tumors 54 precancerous cervical lesions 54 atherosclerotic lesions 54 triacylglycerol concentrations 54 menopausal symptoms 54 ApoE4 gene 54 distal colon 54 hawthorn extract 54 HbF 54 CC genotype 54 bisphosphonate 54 MS relapses 54 residual confounding 54 non aspirin NSAIDs 54 gene variation 54 TT genotype 54 abnormal Pap smears 54 aromatase inhibitors AIs 54 birthweight 54 BLLs 54 CARDIA study 54 lymph node removal 54 familial pancreatic cancer 54 PSA velocity 54 Screening Trial DMIST 54 paricalcitol 54 skin wrinkling 54 BRCA2 gene mutation 54 coenzyme Q# 54 dexrazoxane 54 aromatase inhibitor therapy 54 nondrinkers 54 abdominal fat 54 AAT deficiency 54 prophylactic mastectomies 54 hormone blockers 54 Sexual dysfunction 54 irregular ovulation 54 urinary calcium 54 congenital malformations 54 vitamin K1 54 Digital Mammographic Imaging 54 hyperemesis gravidarum 54 plasma triglycerides 54 folic acid supplement 54 intra abdominal fat 54 lowfat diet 54 serum IGF 54 PSA screening 54 lumbar disk herniation 54 unmeasured confounding 54 Adequate vitamin D 54 unprotected vaginal 54 tamoxifen raloxifene 54 tumor histology 54 onset sepsis 54 folic acid deficiency 54 estrogen metabolism 54 coronary artery calcium 54 serous ovarian cancer 54 distant metastases 54 hyperplastic polyps 54 serum urate levels 54 non vertebral fractures 54 abnormal pap smear 54 obstetric interventions 54 hormone therapy 54 overt hypothyroidism 54 thyroid dysfunction 54 egg follicles 54 LNG IUS 54 anticonvulsant medications 54 salivary flow 54 fetuin 54 fluoroquinolone resistance 54 periodontal diseases 54 CARDIA 54 metachronous 54 hormone deprivation 54 tumor recurrence 54 FTO variant 54 lung metastasis 54 multiple gestations 54 telomere length 54 vaginal atrophy 54 preventive mastectomy 54 plasma homocysteine 54 parous 54 LDL oxidation 54 acetabular dysplasia 54 steroid dexamethasone 54 prostate cancers 54 lichen planus 54 paclitaxel eluting stents 54 cruciferous vegetables 54 arterial thickening 54 basal cell cancers 54 gestational diabetes 54 severe rotavirus gastroenteritis 54 Dietary Modification Trial 54 FGFR2 gene 54 urolithiasis 54 adjuvant radiotherapy 54 nonalcoholic steatohepatitis NASH 54 modifiable lifestyle 54 DHEA supplementation 54 invasive cervical cancer 54 hirsutism 54 metastatic lesions 54 H. pylori eradication 54 estrogen hormone 54 androgen excess 54 abdominal obesity 54 clodronate 54 hematopoietic cancers 54 triglyceride concentrations 54 bezafibrate 54 RBC folate 54 hot flushes 54 prednisone prednisolone 54 deCODE BreastCancer TM 54 Cortisol levels 54 pathologic fractures 54 perinatal outcomes 54 serum concentrations 54 faulty BRCA2 gene 54 type2 diabetes 54 lipid lowering medications 54 eosinophil count 54 bone density 54 risk reducing salpingo 54 serum parathyroid hormone 54 androgen suppression therapy 54 estrogen progestin combination 54 retrograde ejaculation 54 Calcium vitamin D 54 biopsied embryos 54 azoospermia 54 cancers 54 gastric adenocarcinoma 54 UVR exposure 54 thromboembolic 54 undergone hysterectomies 54 tamoxifen 54 salivary gland tumors 54 postmenopause 54 metastatic prostate 54 male hormone androgen 54 dietary intake 53 breast asymmetry 53 APOE4 53 colonic polyps 53 bazedoxifene conjugated estrogens 53 BMI percentile 53 vaginal estrogen 53 macrovascular disease 53 androgen depletion therapy 53 Uterine fibroids 53 thyroid function 53 vitamin supplementation 53 dietary sodium 53 hypercholesterolaemia 53 chromosomal disorders 53 impair fertility 53 hypospadias 53 female hormones estrogen 53 breast cancer 53 thyrotropin 53 linoleic acid 53 menopause 53 BRCA testing 53 alemtuzumab treated 53 pharyngeal cancer 53 genital tract infections 53 intermittent exotropia 53 Oestrogen 53 Radical prostatectomy 53 pelvic inflammatory disease 53 asymptomatic hypothyroidism 53 chromosomal alterations 53 HIV HCV coinfected 53 genetic variants associated 53 herpes infection 53 hsCRP levels 53 nocturnal hypoglycaemia 53 thrombophilia 53 dietary fat 53 phthalate metabolites 53 LUTS 53 neurologic complications 53 breast tumors 53 urinary calcium excretion 53 fasting insulin 53 cancerous breast 53 breast cancer Narod 53 epigenetic changes 53 folate intakes 53 prepregnancy BMI 53 chromosomal abnormalities 53 tamsulosin 53 Ovarian cysts 53 abruption 53 fibrate drugs 53 adiposity 53 dizygotic twins 53 repigmentation 53 elevated hsCRP 53 depot medroxyprogesterone acetate 53 ALND 53 colorectal cancer CRC 53 vulvar cancers 53 Stomach cancer 53 DVT PE 53 BMD measurements 53 angiographic restenosis 53 vaginal flora 53 Young Adults CARDIA 53 male hormones androgens 53 wholegrain foods 53 Zyclara Cream 53 dutasteride 53 chlamydia infection 53 tiotropium bromide 53 HER2 overexpression 53 CMV disease 53 facial wrinkling 53 asymptomatic carotid stenosis 53 papillary thyroid cancer 53 lifetime abstainers 53 serum folate 53 HDL cholesterol 53 HER2 positive breast cancer 53 Postmenopausal 53 vaginal hysterectomy 53 Lowering cholesterol 53 esophageal squamous cell carcinoma 53 undergone radical prostatectomy 53 vaccine serotypes 53 endocrine tumors 53 oral contraceptives 53 dietary intakes 53 severe menopausal symptoms 53 Oral contraceptive 53 Boffetta 53 Clinical Endocrinology & 53 urinary BPA 53 endometriosis 53 carbohydrate intolerance 53 post thrombotic syndrome 53 androgen therapy 53 unexplained infertility 53 trans palmitoleic acid 53 bone thinning 53 mammary cancers 53 beta blocker therapy 53 postmenopausal estrogen 53 vaginal cancers 53 phyto oestrogens 53 peritoneal cancer 53 de ath 53 Hormone therapy 53 fragility fracture 53 hydroxymethyl coenzyme 53 knee osteoarthritis OA 53 cyclic HMB 53 Vitamin D supplementation 53 serious pneumococcal infections 53 malignant lymphoma 53 vitamin E 53 endometrial 53 colorectal tumor 53 azelaic acid 53 varicoceles 53 nulliparous 53 Breast Cancer Risk 53 inherited mutations 53 advanced neoplasia 53 Dr. Arthur Klatsky 53 hormone androgen 53 albumin excretion 53 folates 53 breast abscesses 53 lumbar spine BMD 53 β blockers 53 anti androgen 53 Subgroup analyzes 53 SHBG 53 vitamin D deficiency 53 serum creatinine levels 53 lipid levels 53 lipid lowering therapies 53 mitochondrial mutations 53 menstrual bleeding 53 loop diuretics 53 osteosarcomas 53 Concord grape juice 53 uterine rupture 53 oncologic outcomes 53 isoflavone intake 53 chromium supplementation 53 menstrual abnormalities 53 psychotic illnesses 53 Erythropoietic therapies may 53 periodontal infection 53 polyphenol content 53 antihypertensive medications 53 macrosomia 53 visceral fat 53 facial clefts 53 oral clefts 53 quadrivalent vaccine 53 leukaemias 53 subfertile 53 undescended testes 53 Homocysteine levels 53 prolactin levels 53 inflammatory polyarthritis 53 Androgen deprivation therapy 53 serum cholesterol 53 osteoporosis osteopenia 53 mtDNA mutations 53 varicella infection 53 preeclamptic 53 serum retinol 53 Colon polyps 53 hormonal contraceptives 53 bad cholesterol LDL 53 osteoporosis brittle bones 53 postpartum bleeding 53 folate supplements 53 delaying childbirth 53 peripartum cardiomyopathy 53 Candida infection 53 H2 blocker 53 2 diabetes T2D 53 retrospective cohort 53 untreated sleep apnea 53 atypical antipsychotic medications 53 rectal cancers 53 comorbid illnesses 53 Postnatal depression 53 atopic eczema 53 infantile hemangiomas 53 hamartomas 53 precursor lesions 53 gallstone formation 53 postoperative atrial fibrillation 53 ovarian hyperstimulation syndrome OHSS 53 Maternal obesity 53 incontinence episodes 53 ischemic stroke 53 dental fluorosis 53 p# mutations 53 PSADT 53 Estrogen pills 53 intracerebral hemorrhage 53 subtrochanteric 53 Drospirenone 53 pravastatin therapy 53 neutrophil counts 53 fatal IHD 53 alcoholic cirrhosis 53 soy isoflavone 53 breastfed babies 53 root caries 53 Vigorous exercise 53 macrovascular 53 radioiodine therapy 53 colorectal carcinoma 53 beta cryptoxanthin 53 hypovitaminosis D 53 transaminase levels 53 corticosterone levels 53 nondiabetic 53 oxidized phospholipids 53 Framingham Offspring Study 53 genes BRCA1 53 abstinent alcoholics 53 SIDS infants 53 FSAD 53 SE alleles 53 acid suppressive medication 53 Abdominal fat 53 overactive bladder symptoms 53 hormone progestin 53 cardioembolic stroke 53 gonadotropins 53 isoflavone supplement 53 RLS symptoms 53 invasive candidiasis 53 vitamin B6 53 caffeine intake 53 mammary gland tumors 53 relapsed MM 53 adiponectin 53 naturally occurring antioxidant 53 plasma lipid 53 organochlorine compounds 53 lowering homocysteine levels 53 adenomatous 53 prenatal testosterone 53 valacyclovir 53 hyperhomocysteinemia 53 thyroxine 53 KIF6 carriers 53 onset puberty 53 metabolic syndrome 53 multivariate adjustment